The cytokine network in psoriasis has been proven by the therapeutic effectiveness of biologic antibodies that block individual cytokines, including TNF-α, IL-23/IL-12p40, anti-IL-23p19, IL-17A, and IL-17 receptor (135). This evidence concerns the gene IL23A and psoriasis.